Hormonal status in protracted XXXX and in-hospital mortality.

@entity1 @entity251 @entity1420 @entity2990 @entity2494 @entity3124 @entity442 @entity53 @entity701 @entity9027 @entity413
INTRODUCTION: The aim of this study was to determine the relationship between hormonal status and mortality in @entity1 with protracted @entity3124 . METHODS: We conducted a prospective observational study in four medical and surgical intensive care units (ICUs). ICU @entity1 who regained consciousness after 7 days of mechanical ventilation were included. Plasma levels of @entity442 ( @entity442 ), prolactin, thyroid-stimulating hormone, follicle-stimulating hormone, luteinizing hormone, @entity53 , @entity1420 , @entity251 , @entity2494 ( @entity2494 ), @entity9027 ( @entity2990 ) and @entity701 were measured on the first day @entity1 were awake and cooperative (day 1). Mean blood @entity413 from admission to day 1 was calculated. RESULTS: We studied 102 @entity1 : 65 @entity1 and 37 @entity1 (29 of the @entity1 were postmenopausal). Twenty-four @entity1 (24%) died in the hospital. The @entity442 levels were higher and the @entity701 levels were lower in survivors. Mean blood @entity413 was lower in @entity1 who survived, and @entity2494 and @entity2990 were higher in @entity1 who survived. CONCLUSIONS: These results suggest that, on the basis of sex, some endocrine or metabolic markers measured in the postacute phase of @entity3124 might have a prognostic value.
